DE69113675D1 - Verwendung von Naproxen als Mydriatikum. - Google Patents

Verwendung von Naproxen als Mydriatikum.

Info

Publication number
DE69113675D1
DE69113675D1 DE69113675T DE69113675T DE69113675D1 DE 69113675 D1 DE69113675 D1 DE 69113675D1 DE 69113675 T DE69113675 T DE 69113675T DE 69113675 T DE69113675 T DE 69113675T DE 69113675 D1 DE69113675 D1 DE 69113675D1
Authority
DE
Germany
Prior art keywords
mydriatic
naproxen
maintaining
pharmaceutically acceptable
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69113675T
Other languages
English (en)
Other versions
DE69113675T2 (de
Inventor
Giuseppe Benanti
Claudio Bucolo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
S I F I IND FARMACEUTI Soc
Original Assignee
S I F I IND FARMACEUTI Soc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S I F I IND FARMACEUTI Soc filed Critical S I F I IND FARMACEUTI Soc
Application granted granted Critical
Publication of DE69113675D1 publication Critical patent/DE69113675D1/de
Publication of DE69113675T2 publication Critical patent/DE69113675T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69113675T 1990-05-18 1991-03-16 Verwendung von Naproxen als Mydriatikum. Expired - Fee Related DE69113675T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20366A IT1241928B (it) 1990-05-18 1990-05-18 Composizione oftalmica per l'uso nel mantenimento della midriasi oculare

Publications (2)

Publication Number Publication Date
DE69113675D1 true DE69113675D1 (de) 1995-11-16
DE69113675T2 DE69113675T2 (de) 1996-03-21

Family

ID=11166088

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69113675T Expired - Fee Related DE69113675T2 (de) 1990-05-18 1991-03-16 Verwendung von Naproxen als Mydriatikum.

Country Status (7)

Country Link
EP (1) EP0456988B1 (de)
AT (1) ATE128866T1 (de)
DE (1) DE69113675T2 (de)
DK (1) DK0456988T3 (de)
ES (1) ES2080847T3 (de)
GR (1) GR3018349T3 (de)
IT (1) IT1241928B (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58126810A (ja) * 1981-12-24 1983-07-28 Kaken Pharmaceut Co Ltd 抗炎症眼科用液剤およびその製法
JPS5929616A (ja) * 1982-08-10 1984-02-16 Kaken Pharmaceut Co Ltd 抗炎症眼科用液剤およびその製法

Also Published As

Publication number Publication date
IT1241928B (it) 1994-02-01
DE69113675T2 (de) 1996-03-21
ES2080847T3 (es) 1996-02-16
IT9020366A1 (it) 1991-11-18
ATE128866T1 (de) 1995-10-15
EP0456988A3 (en) 1992-12-23
IT9020366A0 (it) 1990-05-18
GR3018349T3 (en) 1996-03-31
DK0456988T3 (da) 1996-02-05
EP0456988A2 (de) 1991-11-21
EP0456988B1 (de) 1995-10-11

Similar Documents

Publication Publication Date Title
DK1514548T3 (da) Topisk ophthalmisk fluprostenol-præparat til behandling af glaukom og okulær hypertension
DK0495421T3 (da) Anvendelse af carragenaner i topiske ophthalmiske sammensætninger
ES2081187T3 (es) Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
DE69121211T2 (de) Applanationstonometer
ES2071227T3 (es) Composicion para gotas para los ojos.
MX9400037A (es) Composicion oftalmica para el tratamiento de glaucoma e hipertension ocular.
FR2630328B1 (fr) Derive de l'histamine, sa preparation et son application en therapeutique
FI911131A (fi) Menetelmä viherkaihia estävien 3-aryylikarbonyyli-1-aminoalkyyli-1H-indoliyhdisteiden valmistamiseksi
ES2160649T3 (es) Nuevos compuestos lactamicos y procedimientos para su preparacion.
ES2124256T3 (es) Arilmorfolina, preparacion y uso.
ATE128866T1 (de) Verwendung von naproxen als mydriatikum.
DK0458587T3 (da) Behandling af okulær hypertension med en synergistisk kombination til ophthalmisk anvendelse
ATE164066T1 (de) Neue pharmazeutische formulierungen von 5-(2- chlor-1-hydroxyethyl)-4-methylthiazol
ES2076054T3 (es) Nuevas amino-alquil-cromonas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
HU9301364D0 (en) Homo-prostaglandines applicables for treatment of hypertension in eyes
DK0453337T3 (da) Anvendelse af hexetidin eller derivater eller salte deraf til fremstilling af et farmaceutisk præparat til oftalmologisk anvendelse
ES2147825T3 (es) Derivados tetraciclicos de la 1,4-oxazina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
RU92006715A (ru) Местноанестезирующее средство для глаз
SE9002067D0 (sv) The pharmacological use of certain cystine derivatives

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee